Sujatha Gurunathan

Blog Post

Simply Stated: What is Myotonic Dystrophy?

By Sujatha Gurunathan | March 24, 2022
Clinical & Scientific Conference
Blog Post

2022 Clinical & Scientific Conference: March 16 Highlights

By Sujatha Gurunathan | March 16, 2022
Blog Post

2022 Clinical & Scientific Conference March 15 Highlights

By Sujatha Gurunathan | March 15, 2022
Clinical & Scientific Conference
Blog Post

2022 Clinical & Scientific Conference March 14 Highlights

By Sujatha Gurunathan | March 14, 2022
Blog Post

Clinical Trial Alert: Phase 1b/2a Study of WVE-N531 in a Subset of People Living with DMD

By Sujatha Gurunathan | March 11, 2022
Blog Post

Research Study Alert: Survey of Pain Self-Management and Well-Being in People with General Pain or with Myotonic Dystrophy

By Sujatha Gurunathan | February 23, 2022
dystrophin
Blog Post

Simply Stated: What is Duchenne Muscular Dystrophy?

By Sujatha Gurunathan | February 16, 2022
Blog Post

Simply Stated: What is Becker Muscular Dystrophy?

By Sujatha Gurunathan | January 6, 2022
Blog Post

FDA Approves argenx’s Vyvgart for Treatment of gMG

By Sujatha Gurunathan | December 20, 2021
Blog Post

Clinical Trial Alert: Phase 2/3 Study of Tideglusib (AMO-02) in Children and Adolescents with Congenital Myotonic Dystrophy

By Sujatha Gurunathan | November 9, 2021